Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

Cologuard is a colon cancer screening test you can do at home. It’s a noninvasive, stool-based test that comes in a kit. You use the kit to collect a stool sample. Then you send the sample to a lab ...

Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates. The highest return rate was seen with a 2-week deadline. This intervention can be easily ...

A newly published study revealed an at-home colon cancer screening test reduces risk of colorectal cancer death by 33%, according to a new study published in JAMA Network Open. Researchers at the Ohio ...

Fecal immunochemical testing (FIT) was more accurate than blood-based testing for detecting advanced precancerous colorectal lesions, a comparative study found. Screening is among the most effective ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

COLUMBUS, Ohio – A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study published in JAMA Network ...

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in the ...

At-home fecal immunochemical test screening was found to reduce risk of colon cancer death by 33%, according to a study published July 19 in JAMA Network Open. Researchers from academic institutions ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...